Yale Podnos is Chief Medical Officer of Oncology Institute, Inc.. Currently has a direct ownership of 104,368 shares of TOI, which is worth approximately $32,354. The most recent transaction as insider was on May 21, 2024, when has been sold 17,530 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 104K
0% 3M change
15.37% 12M change
Total Value Held $32,354

Yale Podnos Transaction History

Date Transaction Value Shares Traded Shares Held Form
May 21 2024
BUY
Grant, award, or other acquisition
-
17,530 Added 14.38%
104,368 Common Stock
Nov 21 2023
SELL
Sale (or disposition) back to the issuer
$3,350 $2.19 p/Share
1,530 Reduced 1.73%
86,838 Common Stock
Nov 14 2023
SELL
Sale (or disposition) back to the issuer
$5,014 $2.39 p/Share
2,098 Reduced 2.32%
88,368 Common Stock
Mar 17 2023
BUY
Grant, award, or other acquisition
-
33,219 Added 26.86%
90,466 Common Stock
Nov 17 2022
BUY
Grant, award, or other acquisition
-
14,164 Added 19.83%
57,247 Common Stock
Nov 15 2022
SELL
Sale (or disposition) back to the issuer
$403 $2.03 p/Share
199 Reduced 0.46%
43,083 Common Stock
Mar 21 2022
BUY
Grant, award, or other acquisition
-
14,884 Added 25.59%
43,282 Common Stock
Nov 12 2021
BUY
Grant, award, or other acquisition
-
28,398 Added 62.5%
17,039 Common Stock
YP

Yale Podnos

Chief Medical Officer
Cerritos, CA

Track Institutional and Insider Activities on TOI

Follow Oncology Institute, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TOI shares.

Notify only if

Insider Trading

Get notified when an Oncology Institute, Inc. insider buys or sells TOI shares.

Notify only if

News

Receive news related to Oncology Institute, Inc.

Track Activities on TOI